Monashee Investment Management
Latest statistics and disclosures from Monashee Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IVV, VOO, VEA, IEFA, VWO, and represent 71.52% of Monashee Investment Management's stock portfolio.
- Added to shares of these 10 stocks: IVV (+$119M), VOO (+$118M), VEA (+$74M), IEFA (+$55M), VWO (+$39M), IEMG (+$33M), ITOT (+$23M), VTI (+$23M), PCG, Korro Bio.
- Started 30 new stock positions in KPTI, VEA, RWAY, EYPT, BLUE, PCG, ITOT, KNTK, IVV, Korro Bio.
- Reduced shares in these 10 stocks: GPCR (-$18M), ARM (-$12M), STX (-$7.6M), ALIT (-$6.8M), CART (-$6.1M), Alarm Com Hldgs (-$6.0M), CNM (-$5.8M), Docusign (-$5.7M), CRGY (-$5.6M), Livongo Health (-$5.4M).
- Sold out of its positions in Alarm Com Hldgs, ALIT, Ambrx Biopharma, AMKR, AMPH, APO.PA, ARM, ASUR, Atlas Energy Solutions, Blackline.
- Monashee Investment Management was a net buyer of stock by $334M.
- Monashee Investment Management has $567M in assets under management (AUM), dropping by 136.66%.
- Central Index Key (CIK): 0001627608
Tip: Access up to 7 years of quarterly data
Positions held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Monashee Investment Management
Monashee Investment Management holds 44 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Ishares Tr Core S&p500 Etf (IVV) | 21.0 | $119M | NEW | 249k | 477.63 |
|
Vanguard Index Fds S&p 500 Etf Shs (VOO) | 20.9 | $118M | NEW | 271k | 436.80 |
|
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA) | 13.1 | $74M | NEW | 1.5M | 47.90 |
|
Ishares Tr Core Msci Eafe (IEFA) | 9.7 | $55M | NEW | 782k | 70.35 |
|
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) | 6.8 | $39M | NEW | 943k | 41.10 |
|
Ishares Core Msci Emkt (IEMG) | 5.9 | $33M | NEW | 661k | 50.58 |
|
Ishares Tr Core S&p Ttl Stk (ITOT) | 4.0 | $23M | NEW | 217k | 105.23 |
|
Vanguard Index Fds Total Stk Mkt (VTI) | 4.0 | $23M | NEW | 96k | 237.22 |
|
Structure Therapeutics Sponsored Ads (GPCR) | 1.4 | $7.8M | -69% | 192k | 40.76 |
|
Aercap Holdings Nv SHS (AER) | 1.2 | $6.7M | +50% | 90k | 74.32 |
|
PG&E Corporation (PCG) | 0.8 | $4.7M | NEW | 260k | 18.03 |
|
Korro Bio | 0.8 | $4.4M | NEW | 91k | 47.93 |
|
Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $4.0M | NEW | 175k | 23.11 |
|
Celldex Therapeutics Com New (CLDX) | 0.7 | $4.0M | NEW | 100k | 39.66 |
|
Roivant Sciences SHS (ROIV) | 0.7 | $3.9M | -36% | 350k | 11.23 |
|
Argenx Se Sponsored Adr (ARGX) | 0.7 | $3.8M | +33% | 10k | 380.43 |
|
Las Vegas Sands (LVS) | 0.7 | $3.7M | NEW | 75k | 49.21 |
|
Gossamer Bio (GOSS) | 0.6 | $3.2M | -34% | 3.5M | 0.91 |
|
Ambrx Biopharma | 0.5 | $3.0M | NEW | 208k | 14.24 |
|
Immunovant (IMVT) | 0.5 | $2.9M | -58% | 70k | 42.13 |
|
Springworks Therapeutics (SWTX) | 0.5 | $2.7M | NEW | 74k | 36.50 |
|
Permian Resources Corp Class A Com (PR) | 0.4 | $2.4M | -64% | 176k | 13.60 |
|
Fluence Energy Com Cl A (FLNC) | 0.4 | $2.4M | NEW | 100k | 23.85 |
|
Vaxcyte (PCVX) | 0.4 | $2.4M | NEW | 38k | 62.80 |
|
Vesta Real Estate Corp Ads (VTMX) | 0.4 | $2.2M | NEW | 55k | 39.62 |
|
Kinetik Holdings Com New Cl A (KNTK) | 0.4 | $2.2M | NEW | 65k | 33.40 |
|
Klaviyo Com Ser A (KVYO) | 0.3 | $1.9M | -57% | 69k | 27.78 |
|
Aura Biosciences (AURA) | 0.3 | $1.8M | NEW | 198k | 8.86 |
|
Hci (HCI) | 0.3 | $1.7M | NEW | 20k | 87.40 |
|
Corebridge Finl (CRBG) | 0.3 | $1.6M | NEW | 75k | 21.66 |
|
89bio (ETNB) | 0.3 | $1.6M | NEW | 140k | 11.17 |
|
Runway Growth Finance Corp (RWAY) | 0.2 | $1.2M | NEW | 92k | 12.62 |
|
Alpine Immune Sciences (ALPN) | 0.2 | $964k | NEW | 75k | 12.89 |
|
Myriad Genetics (MYGN) | 0.2 | $957k | NEW | 50k | 19.14 |
|
Compass Therapeutics (CMPX) | 0.1 | $780k | -59% | 500k | 1.56 |
|
Shattuck Labs (STTK) | 0.1 | $713k | NEW | 100k | 7.13 |
|
An2 Therapeutics (ANTX) | 0.1 | $697k | -65% | 34k | 20.49 |
|
Bluebird Bio (BLUE) | 0.1 | $690k | NEW | 500k | 1.38 |
|
Wave Life Sciences SHS (WVE) | 0.1 | $522k | NEW | 103k | 5.05 |
|
Molecular Templates Com New (MTEM) | 0.1 | $455k | -14% | 122k | 3.73 |
|
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.1 | $293k | 369k | 0.79 |
|
|
Vivid Seats Com Cl A (SEAT) | 0.0 | $190k | -40% | 30k | 6.32 |
|
Purecycle Technologies (PCT) | 0.0 | $48k | 12k | 4.05 |
|
|
Karyopharm Therapeutics (KPTI) | 0.0 | $35k | NEW | 132k | 0.26 |
|
Past Filings by Monashee Investment Management
SEC 13F filings are viewable for Monashee Investment Management going back to 2015
- Monashee Investment Management 2023 Q4 filed Feb. 12, 2024
- Monashee Investment Management 2023 Q3 filed Nov. 13, 2023
- Monashee Investment Management 2023 Q2 filed Aug. 10, 2023
- Monashee Investment Management 2023 Q1 filed May 5, 2023
- Monashee Investment Management 2022 Q4 filed Feb. 9, 2023
- Monashee Investment Management 2022 Q3 filed Nov. 1, 2022
- Monashee Investment Management 2022 Q2 filed Aug. 12, 2022
- Monashee Investment Management 2022 Q1 filed May 12, 2022
- Monashee Investment Management 2021 Q4 filed Feb. 7, 2022
- Monashee Investment Management 2021 Q3 filed Nov. 9, 2021
- Monashee Investment Management 2021 Q2 filed Aug. 12, 2021
- Monashee Investment Management 2021 Q1 filed May 14, 2021
- Monashee Investment Management 2020 Q4 filed Feb. 11, 2021
- Monashee Investment Management 2020 Q3 filed Nov. 13, 2020
- Monashee Investment Management 2020 Q2 filed Aug. 11, 2020
- Monashee Investment Management 2020 Q1 filed May 13, 2020